4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-26-002840
General Counsel acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anderman Jonathan General Counsel | 2026-04-29 | Grant or award | +25,000 | $1.89 | $47,250 | 196,000 | D |
Loading xslF345X06/ownership.xml…